AI Science Tracker
EN

Learned stromal expression score associates with colon-cancer outcomes

Southern Medical University; Sun Yat-sen University · 30 Apr 2022 · medicine

Discovery

Learned stromal expression score associates with colon-cancer outcomes

Source check: Source checked. Not independent scientific confirmation.

Finding: A 31-gene score selected using elastic-net and penalized survival learning was associated with worse relapse-free and overall survival in retrospective colon-cancer data. A higher score also showed adverse-outcome associations in a separate TCGA cohort. The result is a clinical expression–outcome association, not proof of chemotherapy resistance or a treatment-selection benefit.

Technology: Elastic-net learning; LASSO-Cox feature selection

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Elastic-net models learn stromal-group discriminators, and repeated penalized Cox fits select the expression features that constitute the measured-outcome-associated score.
Test and result
The score was developed using five GEO datasets totalling 990 cases and examined in 382 TCGA-COAD cases. Outcome-informed resampling and expression cutoffs selected genes; the final score subtracts the mean expression of negatively signed selected genes from the positive group. The source reports adjusted survival associations.
Limitation / still unknown
Prognostic outcomes inform development, selection and cutoffs; derivation-cohort associations are not independent validation. Treatment comparisons are observational and do not identify causal benefit or intrinsic resistance. Computational drug-response and pathway predictions are not measured clinical response. Supplemental implementation and treatment-confounding details were not inspected; separate experimental mechanisms are not represented.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9118126/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Exact primary front and selected computational/clinical Methods and corresponding high-level Results; operational laboratory protocols excluded from review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.